Actively Recruiting
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Led by David Blum · Updated on 2025-07-10
382
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
Sponsors
D
David Blum
Lead Sponsor
Z
Zurich University of Applied Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
CONDITIONS
Official Title
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with established diagnosis of a metastatic cancer or severe illness with limited life expectancy receiving palliative care services
- Estimated life expectancy less than 24 months (physician's guess) and more than 3 months
- Karnofsky Index 50% or higher or ECOG score 2 or less
- Aged over 18 years
- Owns and uses a smartphone
- Provides written informed consent
You will not qualify if you...
- Patients under curative treatment
- Relevant cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091
Actively Recruiting
Research Team
D
David Blum, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here